Prot# LPS15023: Open-label, Interventional, Cohort Study to Evaluate Long-Term Safety of Dupilumab in Patients with Moderate to Severe Asthma who Completed the TRAVERSE-LTS12551 Clinical Trial

Project: Research project

Project Details

StatusFinished
Effective start/end date2/6/192/6/20

Funding

  • Quintiles, Inc. (Prot# LPS15023)
  • Sanofi US Services Inc. (Prot# LPS15023)